Change over period: —
NSE · AHCL
AHCL
-30.1% from the 52-week high · +135.2% above the low
Anlon Healthcare Ltd manufactures pharmaceutical formulations, nutraceuticals, and health supplements. The company serves domestic and international markets with tablets, capsules, and wellness products. Its operations include research, production, quality assurance, and regulatory compliance. By delivering safe and effective health solutions, it contributes to overall well-being.
The short version. Return on equity was 12.4% in Mar 2026. Promoter holding was 52.68% in Sep 2026, up 0.00 points over 6 quarters.
1 · The price
How has the stock traded?
AHCL trades 30.1% below its 52-week high and 135.2% above its 52-week low.
2 · The business
Is it growing?
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | |
|---|---|---|---|
| Revenue | 106 | 88 | 51 |
| Net profit | 13 | 8 | 10 |
| Net margin % | 12.7 | 9.5 | 20.6 |
| EPS (₹) | 0.25 | 0.16 | 0.2 |
Annual
| FY2026 | |
|---|---|
| Revenue | 172 |
| Net profit | 29 |
| Net margin % | 16.6 |
| EPS (₹) | 0.54 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 12.4% in Mar 2026; debt to equity is 0.19.
Profitability · 1 years
Returns and margins
| Mar 2026 | |
|---|---|
| Return on equity % | 12.4 |
| Return on capital % | 17.4 |
| EBITDA margin % | 27.7 |
| Net margin % | 16.6 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Unchanged over 6 quarters.
Down 13.42 pts over 6 quarters.
Down 4.05 pts over 6 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|
| Promoter | 52.68 | 52.68 | 52.68 | 52.68 | 52.68 | 52.68 | 0.0 |
| FII | 14.42 | 0 | 0.23 | 0.32 | 1.67 | 1.0 | -13.42 |
| DII | 4.35 | 2.83 | 4.49 | 4.6 | 1.22 | 0.3 | -4.05 |
| Public | 28.55 | 44.49 | 42.6 | 42.4 | 44.43 | 46.02 | +17.47 |
Mutual fund holdings · Oct 2026
2 schemes hold this stock
2 the month before.
- Motilal Oswal BSE Healthcare ETF0.04% of NAV
- Bandhan BSE Healthcare Index Fund0.04% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for AHCL are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about AHCL
What is the AHCL share price?
AHCL (AHCL) last closed at ₹25.00, down 1.77% on the day. Its 52-week range is ₹10.82 to ₹36.39.
What is the market cap of AHCL?
AHCL has a market capitalisation of about ₹1,352 crore. Its price-to-earnings ratio is 32.4.
How are AHCL's latest results?
Return on equity was 12.4% in Mar 2026. Promoter holding was 52.68% in Sep 2026, up 0.00 points over 6 quarters.
Who owns AHCL?
As of Sep 2026, shareholding was: Promoter 52.68%, FII 1.0%, DII 0.3%, Public 46.02%.
How many mutual funds hold AHCL?
2 mutual fund schemes held AHCL in October 2026. That compares with 2 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 24 Apr 2026 · Bonus issue 1:1
- 24 Apr 2026 · Stock Split From Rs.10/- to Rs.2/-
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.